CAS: 1373029-10-7 - 1,4-Bis(1,1-dimethylethyl) tetrahydro-6-methylene-1H-1,4-diazepine-1,4(5H)-dicarboxylate
Formula:C16H28N2O4
InChI:InChI=1S/C16H28N2O4/c1-12-10-17(13(19)21-15(2,3)4)8-9-18(11-12)14(20)22-16(5,6)7/h1,8-11H2,2-7H3
InChI key:InChIKey=GZYVFRGOAGIHKA-UHFFFAOYSA-N
SMILES:O=C(OC(C)(C)C)N1CC(=C)CN(C(=O)OC(C)(C)C)CC1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Di-Tert-Butyl 6-Methylene-1,4-Diazepane-1,4-Dicarboxylate REF: IN-DA00HUV6CAS: 1373029-10-7 | 95% | To inquire | Tue 10 Dec 24 |
 | DI-TERT-BUTYL 6-METHYLENE-1,4-DIAZEPANE-1,4-DICARBOXYLATE REF: 10-F469581CAS: 1373029-10-7 | 95.0% | To inquire | Mon 16 Dec 24 |
 | 1,4-di-tert-butyl 6-methylidene-1,4-diazepane-1,4-dicarboxylate REF: 3D-YEC02910CAS: 1373029-10-7 | Min. 95% | - - - | Discontinued product |
Di-Tert-Butyl 6-Methylene-1,4-Diazepane-1,4-Dicarboxylate
CAS:1373029-10-7
Formula:
C16H28N2O4
Purity:
95%
Molecular weight:
312.4045
Ref: IN-DA00HUV6
| 1g | To inquire | ||
| 2g | To inquire | ||
| 5g | To inquire | ||
| 100mg | 465.00 € | ||
| 250mg | 563.00 € | ||
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
DI-TERT-BUTYL 6-METHYLENE-1,4-DIAZEPANE-1,4-DICARBOXYLATE
CAS:1373029-10-7
Purity:
95.0%
Molecular weight:
312.4100036621094
Ref: 10-F469581
| 1g | To inquire | ||
| 2g | To inquire | ||
| 5g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
1,4-di-tert-butyl 6-methylidene-1,4-diazepane-1,4-dicarboxylate
CAS:1373029-10-7
Please enquire for more information about 1,4-di-tert-butyl 6-methylidene-1,4-diazepane-1,4-dicarboxylate including the price, delivery time and more …
Formula:
C16H28N2O4
Purity:
Min. 95%
Molecular weight:
312.41 g/mol
Ref: 3D-YEC02910
| 1g | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
